Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment
Open Access
- 1 August 2002
- Vol. 57 (8) , 672-676
- https://doi.org/10.1136/thorax.57.8.672
Abstract
Background: A study was undertaken to evaluate Chlamydia pneumoniae chronic infection, other respiratory infections, and functional impairment in patients with chronic bronchitis (stage 1) and to examine chronic C pneumoniae infection, rate of acute exacerbations of chronic bronchitis, and rate of C pneumoniae eradication following antibiotic treatment (stage 2). Methods: In the stage 1 study respiratory specimens from 42 patients with steady state chronic bronchitis were analysed for Gram staining, sputum culture, and C pneumoniae DNA detection by nested touchdown polymerase chain reaction (PCR). On the basis of the results of stage 1, a second population of 141 consecutive patients with steady state mild to moderate chronic bronchitis (FEV1 ≥50% predicted) was studied. On admission, at regular intervals, and at exacerbation all patients underwent serological testing for C pneumoniae (microimmunofluorescence) and a nested touchdown PCR to detect C pneumoniae DNA was performed on peripheral blood mononuclear cells (PBMCs). Patients were assessed over a 12 month period. Information regarding the previous 12 months was taken from medical records. Results: Chronic colonisation of the sputum with C pneumoniae was significantly associated with lower FEV1 and greater airway bacterial colonisation. On admission to the stage 2 study, 80 patients were PCR negative and 61 were PCR positive. Over the 2 years a mean (SD) of 1.43 (1.32) acute exacerbations occurred in PCR negative patients and 2.03 (1.21) in PCR positive patients (pC pneumoniae reinfection/reactivation was found in two of the 34 patients. The rate of C pneumoniae DNA clearance from blood following treatment was 29% at follow up. Conclusion: Chronic colonisation with C pneumoniae is associated with a higher rate of exacerbations of chronic bronchitis. Long term treatment is required to obtain clearance of the organism from the blood.Keywords
This publication has 26 references indexed in Scilit:
- Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase ExpressionCirculation, 1998
- Transcription factors and asthmaEuropean Respiratory Journal, 1998
- Chlamydia pneumoniaeand its role in chronic obstructive pulmonary diseaseAnnals of Medicine, 1998
- Matrix Metalloproteinase Expression and Production by Alveolar Macrophages in EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patientsThorax, 1997
- Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary diseaseEpidemiology and Infection, 1997
- Growth ofChlamydia pneumoniaein cultured human peripheral blood mononuclear cells and induction of a cytokine responseMicrobial Pathogenesis, 1996
- Chlamydia pneumoniae Antibodies in Chronic Obstructive Pulmonary DiseaseInternational Journal of Epidemiology, 1996
- Chlamydia pneumoniae-Induced Ciliostasis in Ciliated Bronchial Epithelial CellsThe Journal of Infectious Diseases, 1995
- Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.Journal of Clinical Pathology, 1993